Product image of Leverette (Ethinylestradiol, Levonorgestrel | Lactose) supplied by GNH India

Leverette

Active Ingredient:
Ethinylestradiol, Levonorgestrel | Lactose
Origin:
EU

Leverette (Ethinylestradiol, Levonorgestrel | Lactose)

Ethinylestradiol and Levonorgestrel, the active ingredients in Leverette, are a combined oral contraceptive presented as an oral tablet for oral use. They work together to inhibit ovulation, thicken cervical mucus and alter the endometrial lining, thereby preventing pregnancy in women of reproductive age who seek reliable hormonal birth control.

GNH India supplies Leverette as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance for global procurement programs.

Manufacturer / TM Owner

Exeltis Poland Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Leverette, a combined oral contraceptive, is indicated for hormonal birth control.

  • Prevention of pregnancy: provides reliable contraception for women of reproductive age.
  • Menstrual cycle regulation: helps establish regular menstrual bleeding patterns.
  • Management of estrogen‑dependent conditions: may be used under medical supervision to treat acne or dysmenorrhea.

How It Works

  • Ethinylestradiol and levonorgestrel bind to estrogen and progesterone receptors, respectively, suppressing the hypothalamic‑pituitary‑gonadal axis. This inhibition prevents the mid‑cycle luteinizing hormone surge, thereby blocking ovulation. In addition, the progestin component thickens cervical mucus and the estrogen component alters the endometrial lining, creating an environment unfavorable for fertilization and implantation.

Side Effects

Leverette may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like.
  • Breast tenderness: temporary swelling or discomfort.
  • Spotting or breakthrough bleeding: irregular light bleeding.
  • Mood changes: irritability or mild depression.
  • Weight gain: modest increase in body weight.

Serious or Rare Side Effects

  • Deep vein thrombosis: clot formation in deep veins.
  • Pulmonary embolism: blockage of lung arteries.
  • Stroke: cerebrovascular accident due to clot or bleed.
  • Hepatic adenoma: benign liver tumor.
  • Severe allergic reaction: rash, swelling, anaphylaxis.
  • Hypertension: significant rise in blood pressure.

Precautions & Warnings

Before initiating Leverette, certain precautions should be considered to ensure safe use.

  • Assess risk of thromboembolism: evaluate personal and family history of clotting disorders.
  • Avoid smoking: especially in women over 35 years of age.
  • Monitor blood pressure: check regularly during therapy.
  • Review concomitant medications: consider potential drug interactions.
  • Counsel on missed doses: follow prescribing information for backup contraception.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Leverette can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
  • Certain antiretrovirals (e.g., efavirenz, nevirapine): can lower hormone levels.
  • St. John’s wort: herbal inducer that diminishes contraceptive effect.

Moderate Interactions (Monitor Closely)

  • Antibiotics such as tetracycline or metronidazole: possible slight reduction in effectiveness.
  • Antifungals like fluconazole: may increase hormone concentrations.
  • Antihypertensives (e.g., ACE inhibitors, beta‑blockers): monitor blood pressure changes.
  • Anticonvulsants with moderate enzyme induction (e.g., oxcarbazepine): assess contraceptive reliability.

Frequently Asked Questions

Leverette is a combined oral contraceptive containing ethynylestradiol and levonorgestrel. It is prescribed to prevent pregnancy in women of reproductive age and may also be used to help regulate menstrual cycles or manage certain estrogen‑dependent conditions under medical supervision.

Ethynylestradiol and levonorgestrel act on estrogen and progesterone receptors, respectively, suppressing the hormonal signals that trigger ovulation. The progestin component also thickens cervical mucus and the estrogen component modifies the uterine lining, creating an environment that prevents fertilization and implantation.

The dosing regimen for Leverette is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet according to a specific cycle, but the exact schedule and any missed‑dose instructions must be provided by the prescriber.

Leverette is intended for use only when pregnancy is not desired. It should not be started during pregnancy, and if pregnancy occurs while taking the product, it should be discontinued. Breastfeeding mothers should consult their physician, as hormonal contraceptives may affect milk production and infant exposure.

To order Leverette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Leverette contains the standard dose combination of ethynylestradiol and levonorgestrel, which is comparable to many other combined oral contraceptives on the market. Its efficacy, safety profile, and side‑effect spectrum are similar to other products that use the same hormonal components, though individual tolerability may vary.

Leverette tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect it from moisture, excessive heat, and direct sunlight to maintain product stability.

Leverette is taken orally, usually once daily at the same time each day, following the prescribed cycle (e.g., 21 active tablets followed by a placebo or hormone‑free interval). Swallow the tablet whole with water; do not crush or chew.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, and stroke, especially in women with pre‑existing risk factors. Other rare but severe reactions can involve hepatic adenoma, severe hypertension, and allergic reactions. Prompt medical attention is required if any of these occur.

Leverette is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, known or suspected breast cancer, liver disease, or those who are pregnant or breastfeeding without physician guidance. It should also be avoided by smokers over 35 years of age and by individuals taking medications that strongly reduce its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel | Lactose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT